European Medicines Agency’s Data Protection Notice for the Organisation Management System (OMS) activities
European Medicines Agency’s Data Protection Notice for the Organisation Management System (OMS) activities
European Medicines Agency’s Data Protection Notice for the Organisation Management System (OMS) activities
Records of data processing activity for the Organisation Management System (OMS) activities
Clinical Trials Information System (CTIS): Walk-in clinic - May 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 May 2025, 16:00 (CEST) to 14 May 2025, 17:00 (CEST)
Committee for Medicinal Products for Human Use (CHMP): 19-22 May 2025, European Medicines Agency, Amsterdam, the Netherlands, from 19 May 2025 to 22 May 2025
CTIS newsflash - 16 May 2025
Medicinal products for human use: monthly figures - April 2025
Network Data Steering Group workplan 2025-2028
Public engagement highlights 2024
Organisation chart: Advisory functions
Human medicines European public assessment report (EPAR): Buprenorphine Neuraxpharm, buprenorphine, Date of authorisation: 19/12/2024, Revision: 1, Status: Authorised